CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.
CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Carmen Parra-Cid*, Eduardo Orozco-Castillo, Julieta García-López, Elena Contreras-Figueroa, Laura E. Ramos-Languren, Clemente Ibarra, Alfonso Carreón-Rodríguez, Michael Aschner, Mina Königsberg and Abel Santamaría*
Eka J. Wahjoepramono, Prita R. Asih, Vilia Aniwiyanti, Kevin Taddei, Satvinder S. Dhaliwal, Stephanie J. Fuller, Jonathan Foster, Malcolm Carruthers, Giuseppe Verdile, Hamid R Sohrabi and Ralph N. Martins
Edoardo Spina Department of Clinical and Experimental Medicine University of Messina Policlinico Universitario Via Consolare Valeria Messina (Italy) Biography
Biography of Edoardo Spina
Dr. Spina graduated in Medicine, specialized in Neurology and in Psychiatry at the University of Messina, Italy. He obtained a doctorate (Ph.D) in Clinical Pharmacology at Karolinska Institute, Stockholm. Currently, Dr. Spina is Professor of Pharmacology at the Department of Clinical and Experimental Medicine, University of Messina. His main scientific interest is clinical neuropsychopharmacology. Dr. Spina authored more than 200 articles in international journals and 2 books. He is Associate Editor of Frontiers in Pharmacogenetics and member of the editorial board of Therapeutic Drug Monitoring, Basic & Clinical Pharmacology & Toxicology and Neuropsychiatric Disease and Treatment.